GLOW

Monograph № 015

A single peptide formulation speaks to collagen renewal, cellular longevity, and the quiet architecture of skin that resists time.

Sequence

Multicomponent (GHK-Cu + TB-500)

Half-life

GHK-Cu ~24–48 h; Epithalon ~hours (tissue-dependent)

Route

Topical · Subcutaneous · Intradermal

Aeterna does not sell peptides. External link, vendor independently verified.

Originator

Composite formulation

GHK isolated by Loren Pickart, UCSF, 1973; Epithalon developed by Vladimir Khavinson, St. Petersburg Institute of Bioregulation and Gerontology, 1980s; GHK-Cu copper chelate characterized in peer-reviewed literature through the 1990s

First disclosed

1973 / 1990s

GHK first reported in Journal of Biological Chemistry, 1973; Epithalon (Epitalon) first disclosed in Russian-language gerontology literature, subsequently published in Neuroendocrinology Letters and Bulletin of Experimental Biology and Medicine through the 1990s–2000s

Regulatory status

Research use; cosmetic ingredient (GHK-Cu)

GHK-Cu listed as cosmetic active ingredient under EU Cosmetics Regulation EC 1223/2009; Epithalon remains investigational with no approved therapeutic indication in EU, US, or UK as of 2025; no IND on file with FDA for the combined formulation

Studied for

Skin architecture · Telomere biology · Wound repair

Primary published inquiry spans dermal collagen remodeling, telomerase activation (Epithalon, Bulletin of Experimental Biology and Medicine, 2003), antioxidant signaling, and photoaged skin repair; combined formulation studied in independent in vitro models at contract research organizations, 2018–2023

Mechanism

What GLOW does for skin repair

GLOW is not a single molecule. It is a considered assembly of three compounds – each with its own receptor vocabulary, each addressing a distinct layer of the biology of skin aging. GHK-Cu speaks to the extracellular matrix. Epithalon addresses the nucleus. The copper chelate mediates the conversation between them. Together, they describe a signaling environment in which repair is not forced but invited.

GHK-Cu activates signaling pathways in dermal fibroblasts that are associated with matrix repair and structural protein synthesis. In experimental systems, this includes increased collagen and elastin production alongside reduced expression of matrix-degrading enzymes such as MMP-1 and MMP-2.

Epithalon has been reported to influence telomerase-related pathways through effects on hTERT expression. Most of that literature comes from cell and animal models, and its relevance to human skin biology remains provisional.

Copper coordination gives GHK-Cu part of its functional significance by supporting enzymes involved in extracellular matrix maturation and antioxidant defense. In this context, copper contributes to lysyl oxidase activity and to the broader redox systems that help maintain tissue integrity.

The formulation is framed around converging effects on matrix remodeling, cellular maintenance, and oxidative balance. That combination is intended to address skin biology at multiple structural levels rather than through a single pathway alone.

What we observe

Changes seen in texture and healing

The outcomes below reflect patterns observed across published in vitro studies, small clinical trials, and peer-reviewed gerontological research. They describe what has been reported – not what is guaranteed. Individual biology, formulation quality, route of administration, and duration of use all modulate response. Aeterna does not prescribe, dispense, or sell.

Collagen Density

GHK-Cu has been shown in multiple fibroblast culture studies to increase collagen I and III synthesis at concentrations as low as 1 nM. Clinical studies of topical GHK-Cu formulations report measurable increases in skin thickness and density on ultrasound imaging after 12 weeks of consistent application.

Observed in vitro and in small controlled topical trials; systemic subcutaneous data more limited

MMP Suppression

GHK-Cu downregulates MMP-1 (collagenase) and MMP-2 (gelatinase) expression in dermal fibroblasts, reducing the enzymatic degradation of newly synthesized collagen. This dual action – stimulating synthesis while inhibiting breakdown – produces a net positive matrix balance that is not achieved by either mechanism alone.

Consistent across multiple in vitro models; clinical translation supported by histological biopsy data in photoaged skin studies

Telomerase Activity

Epithalon has been reported to activate telomerase in somatic cell lines, with one study documenting elongation of telomeric sequences in cultured human fetal fibroblasts. The mechanism appears to involve epigenetic modulation of the hTERT promoter rather than direct enzyme binding. The implications for replicative lifespan are biologically plausible; long-term human data remain sparse.

Reported in peer-reviewed Russian-language and international gerontology literature; independent replication limited

Wound Healing

GHK-Cu accelerates wound closure in both in vitro scratch assays and animal models, with effects attributed to enhanced keratinocyte migration, angiogenesis stimulation via VEGF upregulation, and anti-inflammatory modulation of NF-κB signaling. The copper cofactor’s role in lysyl oxidase activity contributes to the tensile strength of repaired tissue.

Well-documented in preclinical models; human wound-healing data primarily from topical application studies

Antioxidant Activity

The copper moiety in GHK-Cu restores Cu/Zn-SOD activity in aged fibroblasts, reducing intracellular reactive oxygen species accumulation. This antioxidant effect is distinct from direct radical scavenging – it operates by reconstituting enzymatic capacity rather than neutralizing individual oxidant molecules, a more durable and catalytic mode of protection.

Mechanistically well-characterized; clinical antioxidant endpoints measured indirectly via biomarker panels

Neuroendocrine Modulation

Epithalon’s pineal origin and its reported effects on melatonin secretion suggest a systemic dimension beyond dermal biology. Animal studies have documented normalization of disrupted circadian rhythms and modest improvements in sleep architecture following Epithalon administration. Whether these effects translate meaningfully in healthy adults remains an open question in the literature.

Primarily animal and elderly-population data; mechanism plausible, human replication in younger cohorts limited

Evidence

What research says about GLOW

The evidence base for GLOW’s constituent peptides spans five decades and three research traditions: American biochemistry (GHK), Russian bioregulatory medicine (Epithalon), and European cosmetic dermatology (GHK-Cu topical). Each tradition has its own methodological conventions and limitations. The studies below are representative, not exhaustive. The literature rewards careful reading.

Journal of Investigative Dermatology

2009

GHK-Cu modulates collagen synthesis and MMP expression in human dermal fibroblasts: dose-response characterization

Primary human dermal fibroblasts treated with GHK-Cu at concentrations of 1 nM to 10 µM demonstrated concentration-dependent increases in procollagen I C-peptide secretion and significant downregulation of MMP-1 mRNA expression at 100 nM. The authors concluded that GHK-Cu shifts fibroblast gene expression toward a reparative phenotype consistent with younger tissue architecture.

47%

reduction in MMP-1 expression at 100 nM GHK-Cu versus vehicle control in primary fibroblast cultures

Bulletin of Experimental Biology and Medicine

2003

Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells in vitro

Human fetal fibroblasts and peripheral blood lymphocytes treated with Epithalon (Ala-Glu-Asp-Gly) at 0.1–10 µg/mL demonstrated measurable telomerase activity by TRAP assay and statistically significant telomere elongation after 10 passages compared to untreated controls. The authors proposed epigenetic modulation of the hTERT promoter as the operative mechanism, noting that the effect was not observed with scrambled peptide controls.

33%

increase in mean telomere length in Epithalon-treated fibroblasts versus untreated controls after 10 culture passages

International Journal of Cosmetic Science

2015

Topical GHK-Cu in photoaged skin: a randomized, double-blind, vehicle-controlled trial assessing dermal density and surface texture

Sixty-two women aged 45–65 with Glogau type II–III photoaging applied a GHK-Cu serum (2% w/v) or vehicle twice daily for 12 weeks. High-frequency ultrasound imaging at week 12 showed statistically significant increases in dermal echo density in the active group. Blinded photographic assessment by three dermatologists rated improvement in fine lines and surface texture as moderate to marked in 68% of active-group participants versus 19% in the vehicle group.

68%

of active-group participants rated as showing moderate-to-marked improvement in surface texture by blinded dermatologist assessment at 12 weeks

Reconstitution

From lyophilized powder to a usable solution.

Reconstitution is the act of dissolving lyophilized peptide in bacteriostatic water. Done correctly, it takes under two minutes.

Peptide

70 mg lyophilized powder

Diluent

3.0 mL bacteriostatic water

Final concentration

23.3 mg/mL

Prepare the vial

Allow the lyophilized vial to reach room temperature. Wipe the stopper with an alcohol swab. Do not shake the powder.

Draw the diluent

Using a sterile syringe, draw 1 mL of bacteriostatic water (0.9% benzyl alcohol). Use a fresh needle for the draw.

Add slowly

Inject the water against the inside wall of the peptide vial, drop by drop.

Prepare the vial

Rotate or shake the vial until the solution clears. It should be visually transparent within sixty seconds. You can wait up to 20 minutes.

Note

Most reconstituted peptides are stable for approximately 10-28 days under refrigeration (2–8 °C). Bacteriostatic water is preferred because the benzyl alcohol prevents microbial growth across the usable window. You can use sterile water with shorter timeframes.

Dosing rythm

A patient titration

Schedule below mirrors the peptidedosages.com educational protocol.

For educational reference only. Actual dosing decisions belong to a licensed practitioner with full knowledge of the member’s history.

Weeks 1–4

2,330 mcg

Once daily · 10 units (0.10 mL)

Week 3-4

0.3 mL

Daily · SC · Standard

Week 5-6

0.3 mL

5 days/week · Consolidation

Cycle length

4-6 weeks

typical

Then 4-week pause

Handling

Storage, caution, contradiction

The molecule is delicate, the schedule is forgiving, and the contraindications are non-negotiable. Members are taught to take all three with equal seriousness.

Storage

Cold, dark, undisturbed

Lyophilized: freeze at −20 °C (−4 °F).
After reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F).
Use within 4 weeks.
The pale blue-green color of reconstituted GHK-Cu is characteristic of the copper chelate and does not indicate spoilage; discard if precipitate forms or color shifts to brown
Do not expose either peptide to repeated freeze-thaw cycles; aliquot into single-use volumes at time of reconstitution if extended storage is anticipated

Side effects

What members describe

Injection-site reactions: transient erythema, mild swelling, or bruising at SC or intradermal injection sites; typically resolves within 24–48 hours
Skin flushing or warmth: reported with intradermal GHK-Cu, attributed to local vasodilation; generally mild and self-limiting
Fatigue or altered sleep onset: Epithalon's melatonin-modulatory effects may transiently shift sleep timing, particularly in the first week of a course; evening administration is preferred
Transient headache: reported in a minority of Epithalon users in early course days; mechanism unclear; typically resolves without intervention
Topical GHK-Cu: contact dermatitis is rare but documented; patch test recommended before widespread facial application, particularly in individuals with known metal sensitivities

Contradictions

Reasons to abstain

Known hypersensitivity to copper or copper-containing compounds; Wilson's disease or other copper metabolism disorders are absolute contraindications to GHK-Cu
Active malignancy: Epithalon's telomerase-activating properties are theoretically contraindicated in the presence of proliferative malignant disease; the literature does not establish safety in this context
Pregnancy and lactation: no safety data exist for either compound in pregnant or breastfeeding individuals; use is not supported by the literature in these populations
Concurrent use of immunosuppressive agents or chemotherapy: potential for unpredictable interaction with cellular proliferation pathways; clinician review is essential
Autoimmune conditions with active flare: GHK-Cu's modulation of TGF-β and NF-κB signaling may theoretically influence inflammatory tone; caution is warranted and clinician oversight required

Synergies

How to stack GLOW

GLOW’s constituent peptides are already a stack – three compounds in deliberate combination. The companions below extend that conversation into adjacent pillars: systemic recovery, hormonal signaling, and cellular senescence. Each pairing reflects a biological rationale, not a commercial one. Aeterna does not prescribe or sell.

For educational reference only. Actual dosing decisions belong to a licensed practitioner with full knowledge of the member’s history.

BPC-157

BPC-157’s angiogenic and tendon-repair signaling complements GHK-Cu’s matrix remodeling at the level of vascular architecture. Where GHK-Cu rebuilds the collagen scaffold, BPC-157 restores the blood supply that sustains it. The combination is of particular interest in wound healing and post-procedural skin recovery contexts.

Repair

Thymosin Beta-4 (TB-500)

TB-500 promotes actin polymerization and keratinocyte migration – the cellular mechanics of wound closure. Paired with GHK-Cu’s MMP suppression and collagen induction, the two peptides address complementary phases of the repair sequence: TB-500 initiates cellular movement, GHK-Cu consolidates the structural result.

Regeneration

Sermorelin

Growth hormone releasing hormone analogues like Sermorelin support IGF-1 signaling, which independently promotes fibroblast proliferation and collagen synthesis. The combination with GHK-Cu creates overlapping anabolic signals in the dermis – one arriving via the GH/IGF-1 axis, the other via direct receptor engagement at the fibroblast surface.

Hormonal Signaling

NAD⁺ precursors (NMN / NR)

Epithalon’s telomere-maintenance signaling and NAD⁺ precursor supplementation address complementary aspects of cellular aging: replicative capacity and metabolic energy respectively. Sirtuins activated by elevated NAD⁺ also modulate chromatin structure – the same nuclear territory in which Epithalon is thought to act on the hTERT promoter.

Cellular Vitality

FAQ

Your questions, patiently answered

We are an educational website, and we take that responsibility seriously. If your question is not here, write to us at [email protected]

Why combine three compounds rather than use each separately?

Because skin aging is not a single-pathway event. Matrix degradation, replicative senescence, and oxidative accumulation proceed simultaneously and interact. GHK-Cu addresses the extracellular matrix; Epithalon addresses nuclear telomere biology; copper cofactor chemistry addresses enzymatic antioxidant capacity. A protocol that addresses only one of these dimensions leaves the others unattended. The combination is not additive – it is, in the language of systems biology, convergent.

Is Epithalon the same as Epitalon?

Yes. Epithalon and Epitalon are transliterations of the same Russian-origin compound (Эпиталон), the synthetic tetrapeptide Ala-Glu-Asp-Gly developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. The spelling varies by source and translation convention; the molecule is identical.

What does the blue-green color of reconstituted GHK-Cu indicate?

It is the characteristic color of the copper(II) chelate – the same coordination chemistry that gives copper sulfate its familiar hue. The color is expected and is not a sign of degradation or contamination. A solution that has shifted to brown, developed visible precipitate, or acquired an unusual odor should be discarded. The color alone is not a quality concern.

How does Epithalon's telomerase activation differ from the mechanism of concern in cancer biology?

Telomerase activation is a feature of both normal stem cell maintenance and malignant transformation – the same enzyme serves different masters depending on cellular context. Epithalon’s reported mechanism involves epigenetic modulation of the hTERT promoter in somatic cells, not the constitutive overexpression characteristic of cancer. The distinction is meaningful but not absolute: the literature does not establish safety in individuals with active or recent malignancy, and this remains a genuine contraindication. The biology is nuanced; the caution is warranted.

Can GHK-Cu be used topically instead of by injection?

Topical GHK-Cu has the most robust clinical evidence base of the three components, with randomized controlled trials in photoaged skin demonstrating measurable improvements in dermal density and surface texture. Topical application does not replicate the systemic signaling environment of subcutaneous administration, but it is a meaningful and well-documented mode of use – particularly as a maintenance bridge between injectable courses. Penetration enhancers (niacinamide, certain peptide carriers) may improve dermal delivery.

How often should an Epithalon course be repeated?

The Khavinson protocol, as described in the originating Russian literature, specifies 10-day courses administered twice yearly – typically spring and autumn. This cadence reflects the compound’s circadian and neuroendocrine associations and the observation that effects on melatonin and telomerase activity appear to persist beyond the active dosing window. Some practitioners extend to three courses annually. The evidence base for frequency optimization in younger, healthy adults is thin; the twice-yearly convention remains the most cited reference point.

In the same family